COLL stock

Collegium Pharmaceutical Inc (COLL) Becoming More Attractive for Investors
Daniel Torres
Collegium Pharmaceutical Inc’s recent filing unveils that its Director Fallon John A. unloaded Company’s shares for reported $1.65 million on ...

Analysts review Collegium Pharmaceutical Inc’s rating
Samantha Gray
Collegium Pharmaceutical Inc’s recently made public that its EVP & Chief Financial Officer Tupper Colleen unloaded Company’s shares for reported ...

COLL stock price expected to increase by 38 in 12 months
Daniel Torres
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Collegium Pharmaceutical ...





